BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20394697)

  • 21. Breast and cervical cancer screening among women in metropolitan areas of the United States by county-level commuting time to work and use of public transportation, 2004 and 2006.
    Coughlin SS; King J
    BMC Public Health; 2010 Mar; 10():146. PubMed ID: 20302614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study.
    Schumacher MC; Slattery ML; Lanier AP; Ma KN; Edwards S; Ferucci ED; Tom-Orme L
    Cancer Causes Control; 2008 Sep; 19(7):725-37. PubMed ID: 18307048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Controlled Trial of a Cervical Cancer Education Intervention for Latinas Delivered Through Interactive, Multimedia Kiosks.
    Valdez A; Napoles AM; Stewart SL; Garza A
    J Cancer Educ; 2018 Feb; 33(1):222-230. PubMed ID: 27573420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical Cancer Screening Knowledge, Perceptions, and Behaviors in a Multiracial Cohort of Low-Income, Underscreened Women in North Carolina.
    Bukowski A; Smith JS; Wheeler SB; Sanusi B; McGuire FH; Zeno E; Des Marais AC; Barclay L; Hudgens MG; Jackson S; Brewer NT
    J Womens Health (Larchmt); 2023 Sep; 32(9):970-981. PubMed ID: 37327372
    [No Abstract]   [Full Text] [Related]  

  • 26. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD; Lin RS
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
    Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
    AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual- and county-level predictors of cervical cancer screening: a multi-level analysis.
    Akinlotan MA; Weston C; Bolin JN
    Public Health; 2018 Jul; 160():116-124. PubMed ID: 29803186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
    MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
    J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
    Katz SJ; Hofer TP
    JAMA; 1994 Aug; 272(7):530-4. PubMed ID: 8046807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
    Tavasoli SM; Kane E; Chiarelli AM; Kupets R
    Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of papanicolaou smears by South Asian women living in the United States.
    Chaudhry S; Fink A; Gelberg L; Brook R
    J Gen Intern Med; 2003 May; 18(5):377-84. PubMed ID: 12795737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population.
    Phaswana-Mafuya N; Peltzer K
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1465-1470. PubMed ID: 29936716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 35. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 37. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with underscreening for cervical cancer among women in Canada.
    Schoueri-Mychasiw N; McDonald PW
    Asian Pac J Cancer Prev; 2013; 14(11):6445-50. PubMed ID: 24377548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Body Mass Index With Adherence to Cervical Cancer Screening Recommendations in Hispanic Women.
    Pérez CM; González-Barrios D; Ramos-Cartagena JM; Ortiz AP
    J Low Genit Tract Dis; 2020 Jan; 24(1):14-20. PubMed ID: 31860570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.